title: Evaluation of the local inflammatory events induced by BpirMP, a metalloproteinase from Bothrops pirajai venom.
abstract: In this study, we evaluated the edema and hyperalgesic response induced by BpirMP, a P-I class metalloproteinase isolated from Bothrops pirajai snake venom. The animals were injected with the metalloproteinase or sterile PBS (control group) and evaluated for 1, 2, 3, 4, 5, 6 and 24h. The intraplantar injection of BpirMP (5-50μg/paw) induced a dose- and time-dependent response. BpirMP (50μg) induced paw edema in rats rapidly, with peak response two hours after injection of the toxin. Also, BpirMP injection caused a significant reduction in the nociceptive threshold of the animals tested, with peak response three hours after injection of the toxin. The inflammatory mediators involved in these responses were assayed by pretreatment of animals with synthesis inhibitors or receptor antagonists. Peak responses were significantly reduced by pretreatment of animals with pyrilamine, a histamine receptor antagonist, sodium cromoglycate, a mast cell degranulation inhibitor and valeryl salicylate and meloxicam, cyclooxygenase inhibitors. The analysis of the peritoneal cavity exudate revealed an acute inflammatory response with recruitment of leukocytes, increased levels of total proteins, nitric oxide and the cytokines IL-6, TNF-α and IL-10. In conclusion, our results demonstrated that BpirMP induces inflammation mediated by mast cell degranulation, histamine, prostaglandins and cytokine production.
authors.affiliation: Departamento de Análises Clínicas, Toxicológicas e Bromatológicas, Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo (FCFRP-USP), Ribeirão Preto, SP, Brazil. Electronic address: carol.petri@gmail.com.
authors.forename: Carolina P
authors.initials: CP
authors.lastname: Bernardes
authors.affiliation: Departamento de Análises Clínicas, Toxicológicas e Bromatológicas, Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo (FCFRP-USP), Ribeirão Preto, SP, Brazil.
authors.forename: Danilo L
authors.initials: DL
authors.lastname: Menaldo
authors.affiliation: Instituto de Ciências Biomédicas, Universidade Federal de Uberlândia (ICBIM-UFU), Uberlândia, MG, Brazil; Instituto Nacional de Ciência e Tecnologia em Nano-Biofarmacêutica (N-Biofar), Belo Horizonte, MG, Brazil.
authors.forename: Carla C N
authors.initials: CC
authors.lastname: Mamede
authors.affiliation: Departamento de Análises Clínicas, Toxicológicas e Bromatológicas, Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo (FCFRP-USP), Ribeirão Preto, SP, Brazil.
authors.forename: Karina F
authors.initials: KF
authors.lastname: Zoccal
authors.affiliation: Departamento de Análises Clínicas, Toxicológicas e Bromatológicas, Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo (FCFRP-USP), Ribeirão Preto, SP, Brazil.
authors.forename: Adélia C O
authors.initials: AC
authors.lastname: Cintra
authors.affiliation: Departamento de Análises Clínicas, Toxicológicas e Bromatológicas, Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo (FCFRP-USP), Ribeirão Preto, SP, Brazil.
authors.forename: Lúcia H
authors.initials: LH
authors.lastname: Faccioli
authors.affiliation: Instituto de Ciências Biomédicas, Universidade Federal de Uberlândia (ICBIM-UFU), Uberlândia, MG, Brazil; Instituto Nacional de Ciência e Tecnologia em Nano-Biofarmacêutica (N-Biofar), Belo Horizonte, MG, Brazil.
authors.forename: Leonilda
authors.initials: L
authors.lastname: Stanziola
authors.affiliation: Instituto de Ciências Biomédicas, Universidade Federal de Uberlândia (ICBIM-UFU), Uberlândia, MG, Brazil; Instituto Nacional de Ciência e Tecnologia em Nano-Biofarmacêutica (N-Biofar), Belo Horizonte, MG, Brazil.
authors.forename: Fabio
authors.initials: F
authors.lastname: de Oliveira
authors.affiliation: Departamento de Análises Clínicas, Toxicológicas e Bromatológicas, Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo (FCFRP-USP), Ribeirão Preto, SP, Brazil. Electronic address: suvilela@usp.br.
authors.forename: Suely V
authors.initials: SV
authors.lastname: Sampaio
mesh_terms: D000818:Animals; D017837:Bothrops / Q000378:metabolism; D015550:Cell Degranulation / Q000276:immunology; D004205:Cromolyn Sodium / Q000494:pharmacology; D003435:Crotalid Venoms / Q000633:toxicity*; D016861:Cyclooxygenase Inhibitors / Q000494:pharmacology; D004487:Edema / Q000139:chemically induced* / Q000276:immunology / Q000473:pathology; D005260:Female; D006634:Histamine H1 Antagonists / Q000494:pharmacology; D006930:Hyperalgesia / Q000139:chemically induced* / Q000276:immunology / Q000473:pathology; D007249:Inflammation / Q000139:chemically induced* / Q000276:immunology / Q000473:pathology; D016753:Interleukin-10 / Q000276:immunology; D015850:Interleukin-6 / Q000276:immunology; D007962:Leukocytes / Q000276:immunology; D008297:Male; D008407:Mast Cells / Q000502:physiology*; D000077239:Meloxicam; D045726:Metalloproteases / Q000633:toxicity*; D051379:Mice; D008807:Mice, Inbred BALB C; D009569:Nitric Oxide / Q000378:metabolism; D059225:Nociception / Q000187:drug effects*; D011738:Pyrilamine / Q000494:pharmacology; D051381:Rats; D017208:Rats, Wistar; D012459:Salicylates / Q000494:pharmacology; D013843:Thiazines / Q000494:pharmacology; D013844:Thiazoles / Q000494:pharmacology; D014409:Tumor Necrosis Factor-alpha / Q000276:immunology; D014757:Viper Venoms / Q000633:toxicity*
chemical_list: D003435:Crotalid Venoms; D016861:Cyclooxygenase Inhibitors; D006634:Histamine H1 Antagonists; C556062:IL10 protein, mouse; D015850:Interleukin-6; D012459:Salicylates; D013843:Thiazines; D013844:Thiazoles; D014409:Tumor Necrosis Factor-alpha; D014757:Viper Venoms; C401835:valerylsalicylate; D016753:Interleukin-10; D009569:Nitric Oxide; C582983:BpirMP protein, Bothrops pirajai; D045726:Metalloproteases; D011738:Pyrilamine; D004205:Cromolyn Sodium; D000077239:Meloxicam
keywords: Bothrops pirajai; Edema; Inflammation; Metalloproteinase; Pain; Snake venom